Spontaneous and induced tolerance for liver transplant recipients
- 1 February 2016
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Organ Transplantation
- Vol. 21 (1), 53-58
- https://doi.org/10.1097/mot.0000000000000268
Abstract
Transformative medical and surgical advances have remarkably improved short-term survival after liver transplantation. There is, however, pervasive concern that the cumulative toxicities of modern immunosuppression regimens severely compromise both quality and quantity of life for liver transplant recipients. The inherently tolerogenic nature of the liver offers the tantalizing opportunity to change the current paradigm of nonspecific and lifelong immunosuppression. Safe minimization or discontinuation of immunosuppression without damage to the liver allograft is an attractive strategy to improve long-term survival after liver transplantation.Recent prospective, multicenter clinical trials have demonstrated that immunosuppression can be safely withdrawn from selected liver transplant recipients with preservation of allograft histology. These successes have spurred multiple avenues of investigation to identify peripheral blood and/or tissue biomarkers and delineate mechanisms of tolerance. Concomitant advances in the ability to expand regulatory T cells in the laboratory have spawned clinical trials to facilitate immunosuppression minimization and/or discontinuation.This review will delineate the unique liver immunobiology that has driven the recent clinical trials to unmask spontaneous tolerance or induce tolerance for liver transplant recipients. The emerging results of these trials over the next 5 years hold promise to reduce the burden of lifelong immunosuppression and thereby optimize the long-term health of liver transplant recipients.Keywords
This publication has 45 references indexed in Scilit:
- HLA-Mismatched Renal Transplantation without Maintenance ImmunosuppressionThe New England Journal of Medicine, 2013
- Chimerism and Tolerance Without GVHD or Engraftment Syndrome in HLA-Mismatched Combined Kidney and Hematopoietic Stem Cell TransplantationScience Translational Medicine, 2012
- Mixed chimerism through donor bone marrow transplantationCurrent Opinion in Organ Transplantation, 2012
- Induced Immune Tolerance for Kidney TransplantationThe New England Journal of Medicine, 2011
- Liver antigen-presenting cellsJournal of Hepatology, 2011
- Immune tolerance: What is unique about the liverJournal of Autoimmunity, 2010
- Tolerance and Chimerism after Renal and Hematopoietic-Cell TransplantationThe New England Journal of Medicine, 2008
- HLA-Mismatched Renal Transplantation without Maintenance ImmunosuppressionThe New England Journal of Medicine, 2008
- Immunological tolerance – the liver effectImmunological Reviews, 2000
- Prolonged survival of liver transplants in the pig.BMJ, 1967